CD27 and systemic lupus erythematosus: While the IgD+CD27− fraction of human peripheral blood B cells is generally considered a naïve population, our studies show significant heterogeneity within this compartment, a feature more readily documented in active SLE patients and primary severe SARS-CoV-2 infection with enhanced EF responses16–19,50.